HSPA5 and central nervous system cancer: In contrast, overexpression of HSPA5 inhibited DHA-induced ROS, MDA and lipid ROS generation and cell death in glioma cells (Fig. 5e and Additional file 1: Figure S8B), suggesting that ATF4-induced HSPA5 might antagonize the pro-ferroptotic activity of DHA.